K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan. It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions. The company was incorporated in 2016 and is based in Minato, Japan.
Stock data | 2024 | Change |
---|---|---|
Price | $5.12 | N/A |
Market Cap | $59.15M | N/A |
Shares Outstanding | 11.56M | N/A |
Employees | 0 | N/A |